HYPR vs TLRY · rev $7.8M vs rev $915.5M
Hyperfine Inc (HYPR) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Hyperfine Inc (HYPR) is a medical devices company listed on NASDAQ.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported HYPR revenue for 2026-06-30 was $7.8M. Net income was -$17.9M. HYPR currently screens at market cap $141.5M.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
HYPR currently screens at market cap $141.5M. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the HYPR and TLRY stock pages for the full models.
Not investment advice.